Soaanz FDA Approval History
Last updated by Judith Stewart, BPharm on June 29, 2021.
FDA Approved: Yes (First approved June 14, 2021)
Brand name: Soaanz
Generic name: torsemide
Dosage form: Tablets
Company: Sarfez Pharmaceuticals
Treatment for: Edema
Soaanz (torsemide) is a loop diuretic indicated for the treatment of edema associated with heart failure or renal disease in adults.
- Soaanz is an improved formulation of the approved loop diuretic torsemide intended to reduce excessive urination. Soaanz has an extended duration of peak effect and takes a longer time to achieve peak effect compared to previous torsemide formulations.
- Soaanz tablets are taken orally once daily.
- Soaanz can cause lightheadedness and possibly syncope. This can happen during the first days of therapy, or when there is a drop in blood pressure due to inadequate fluid intake, excessive perspiration, diarrhea, or vomiting.
Development timeline for Soaanz
| Date | Article |
|---|---|
| Jun 21, 2021 | Approval FDA Approves Soaanz (torsemide) for Edema Treatment in Patients with Heart Failure and Renal Disease |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
